Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Sanguina, LLC secured a $962,375 NIH SBIR/STTR award: Translation of a personalized, non-invasive smartphone app for hemoglobin monitoring for chronic anemia patients
Amount Raised
$962,000
Round Type
Grant
Peachtree CornersInvestors
Description
Anemia, characterized by low blood hemoglobin (Hgb) levels, is the world’s most common blood disorder, afflicting 1.6 billion people, with 80 million at high risk in the US alone. Due to numerous etiologies, anemia can also be chronic and potentially life-threatening. Given the severity and epidemiological impact of anemia, screening is crucial for those at risk for anemia, and those with diagnosed chronic anemia require frequent monitoring. Currently, the gold-standard diagnostic test for anemi
Related People
Funding Insights
Based on industry dataWatching Sanguina? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your plan